RP Management

Latest statistics and disclosures from RP Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are BHVN, CYTK, BCRX, VIRX, and represent 100.00% of RP Management's stock portfolio.
  • RP Management has $228M in assets under management (AUM), dropping by 0.00%.
  • Central Index Key (CIK): 0001507673

Tip: Access up to 7 years of quarterly data

Positions held by RP Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for RP Management

RP Management holds 4 positions in its portfolio as reported in the December 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Biohaven (BHVN) 64.4 $147M 2.9M 49.97
 View chart
Cytokinetics (CYTK) 22.7 $52M 980k 52.80
 View chart
BioCryst Pharmaceuticals (BCRX) 12.8 $29M 3.8M 7.60
 View chart
Viracta Therapeutics (VIRX) 0.0 $851.000000 3.7k 0.23
 View chart

Past Filings by RP Management

SEC 13F filings are viewable for RP Management going back to 2018

View all past filings